Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet

The mean estimate comprises four short-term price targets with a standard deviation of $5.38. While the lowest estimate of $17 indicates a 37.8% increase from the current price level, the most optimistic analyst expects the stock to surge 135% to reach $29. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. But, for CATX, an impressive average price target is not the o ...